<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rajesh D</submitter><funding>NHLBI NIH HHS</funding><pagination>1797-800</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4081297</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>118(7)</volume><pubmed_abstract>Generation of patient-specific induced pluripotent cells (iPSCs) holds great promise for regenerative medicine. Epstein-Barr virus immortalized lymphoblastoid B-cell lines (LCLs) can be generated from a minimal amount of blood and are banked worldwide as cellular reference material for immunologic or genetic analysis of pedigreed study populations. We report the generation of iPSCs from 2 LCLs (LCL-iPSCs) via a feeder-free episomal method using a cocktail of transcription factors and small molecules. LCL-derived iPSCs exhibited normal karyotype, expressed pluripotency markers, lost oriP/EBNA-1 episomal vectors, generated teratomas, retained donor identity, and differentiated in vitro into hematopoietic, cardiac, neural, and hepatocyte-like lineages. Significantly, although the parental LCLs express viral EBNA-1 and other Epstein-Barr virus latency-related elements for their survival, their presence was not detectable in LCL-iPSCs. Thus, reprogramming LCLs could offer an unlimited source for patient-specific iPSCs.</pubmed_abstract><journal>Blood</journal><pubmed_title>Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells.</pubmed_title><pmcid>PMC4081297</pmcid><funding_grant_id>U01 HL107437</funding_grant_id><pubmed_authors>Rajesh D</pubmed_authors><pubmed_authors>Dickerson SJ</pubmed_authors><pubmed_authors>Yu J</pubmed_authors><pubmed_authors>Thomson JA</pubmed_authors><pubmed_authors>Brown ME</pubmed_authors><pubmed_authors>Seay NJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells.</name><description>Generation of patient-specific induced pluripotent cells (iPSCs) holds great promise for regenerative medicine. Epstein-Barr virus immortalized lymphoblastoid B-cell lines (LCLs) can be generated from a minimal amount of blood and are banked worldwide as cellular reference material for immunologic or genetic analysis of pedigreed study populations. We report the generation of iPSCs from 2 LCLs (LCL-iPSCs) via a feeder-free episomal method using a cocktail of transcription factors and small molecules. LCL-derived iPSCs exhibited normal karyotype, expressed pluripotency markers, lost oriP/EBNA-1 episomal vectors, generated teratomas, retained donor identity, and differentiated in vitro into hematopoietic, cardiac, neural, and hepatocyte-like lineages. Significantly, although the parental LCLs express viral EBNA-1 and other Epstein-Barr virus latency-related elements for their survival, their presence was not detectable in LCL-iPSCs. Thus, reprogramming LCLs could offer an unlimited source for patient-specific iPSCs.</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Aug</publication><modification>2020-11-19T09:29:21Z</modification><creation>2019-06-06T12:58:51Z</creation></dates><accession>S-EPMC4081297</accession><cross_references><pubmed>21708888</pubmed><doi>10.1182/blood-2011-01-332064</doi></cross_references></HashMap>